Zhejiang Ausun Pharmaceutical Co Ltd Financial Flexibility Index
Zhejiang Ausun Pharmaceutical Co Ltd financial flexibility index. Zhejiang Ausun Pharmaceutical Co Ltd (603229) has a Financial Flexibility Index of 0.21x as of September 2025. Free cash flow of CN¥149.17 Million (operating CF CN¥121.49 Million minus capex CN¥27.68 Million) represents 0% of total liabilities (CN¥713.05 Million). See Zhejiang Ausun Pharmaceutical Co Ltd free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Zhejiang Ausun Pharmaceutical Co Ltd (2012–2025)
Financial flexibility index of Zhejiang Ausun Pharmaceutical Co Ltd from 2012 to 2025. Historical Financial Flexibility Index trend for Zhejiang Ausun Pharmaceutical Co Ltd across 14 annual periods. Check Zhejiang Ausun Pharmaceutical Co Ltd (603229) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
Zhejiang Ausun Pharmaceutical Co Ltd Financial Flexibility Index by Year (2012–2025)
Zhejiang Ausun Pharmaceutical Co Ltd financial flexibility index by year from 2012 to 2025. Year-by-year free cash flow to debt coverage for Zhejiang Ausun Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see how efficiently does Zhejiang Ausun Pharmaceutical Co Ltd generate cash.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.32x | CN¥260.95 Million | CN¥156.51 Million | CN¥815.89 Million | ▼ -21.4% |
| 2024 | 0.41x | CN¥289.23 Million | CN¥177.93 Million | CN¥710.50 Million | ▼ -14.4% |
| 2023 | 0.48x | CN¥385.32 Million | CN¥221.85 Million | CN¥809.99 Million | ▲ +3.5% |
| 2022 | 0.46x | CN¥392.48 Million | CN¥120.57 Million | CN¥854.19 Million | ▼ -44.6% |
| 2021 | 0.83x | CN¥484.75 Million | CN¥173.90 Million | CN¥584.64 Million | ▼ -8.7% |
| 2020 | 0.91x | CN¥231.43 Million | CN¥138.47 Million | CN¥254.81 Million | ▲ +59.3% |
| 2019 | 0.57x | CN¥137.36 Million | CN¥87.73 Million | CN¥240.96 Million | ▲ +75.0% |
| 2018 | 0.33x | CN¥66.56 Million | CN¥11.50 Million | CN¥204.38 Million | ▼ -43.1% |
| 2017 | 0.57x | CN¥101.15 Million | CN¥46.78 Million | CN¥176.65 Million | ▼ -14.6% |
| 2016 | 0.67x | CN¥136.00 Million | CN¥93.21 Million | CN¥202.76 Million | ▲ +48.7% |
| 2015 | 0.45x | CN¥96.43 Million | CN¥53.63 Million | CN¥213.81 Million | ▲ +84.2% |
| 2014 | 0.24x | CN¥44.53 Million | CN¥21.45 Million | CN¥181.90 Million | ▼ -31.9% |
| 2013 | 0.36x | CN¥52.44 Million | CN¥15.73 Million | CN¥145.87 Million | ▲ +10.8% |
| 2012 | 0.32x | CN¥36.40 Million | CN¥-1.14 Million | CN¥112.21 Million | — |